CA 2024 * | 48,78 Md 45,63 Md 44,55 Md | CA 2025 * | 50,62 Md 47,34 Md 46,23 Md | Capitalisation | 200 Md 187 Md 182 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 10,37 Md 9,7 Md 9,47 Md | Résultat net 2025 * | 11,9 Md 11,12 Md 10,86 Md | VE / CA 2024 * | 4,35 x |
Dette nette 2024 * | 12,65 Md 11,83 Md 11,55 Md | Dette nette 2025 * | 11,18 Md 10,46 Md 10,22 Md | VE / CA 2025 * | 4,17 x |
PER 2024 * |
19,4
x | PER 2025 * |
16,7
x | Employés | 76 057 |
Rendement 2024 * |
3,69% | Rendement 2025 * |
3,82% | Flottant | 85,22% |
Dernier transcript sur Novartis AG
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 48 | 01/01/05 | |
Director of Finance/CFO | 59 | 01/01/03 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 16/05/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 01/01/13 |
Simon Moroney
BRD | Director/Board Member | 65 | 28/02/20 |
Chairman | 68 | 01/01/13 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
ARCHEA FUND PATRIMOINE B1 | Non | 15.91M EUR | +22,00% | |
BÉTELGEUSE | Non | 1.02M EUR | +18,00% | |
BELLATRIX C | Non | 2.41M EUR | +7,00% | |
AXAWF SWITZERLAND EQ A CAP CHF | Non | 16.86M CHF | +7,00% | |
AI NATURAL CPTL TRSTN GLB EQ I USD ACC | Non | 1.05M USD | +13,00% |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 661 Md | |
+27,00% | 566 Md | |
-6,76% | 352 Md | |
+20,34% | 332 Md | |
+3,00% | 283 Md | |
+13,09% | 231 Md | |
-9,61% | 195 Md | |
-6,26% | 145 Md | |
-11,77% | 144 Md |